- Home
- JRSH vs CTOR Comparison
JRSH vs CTOR Comparison
Compare JRSH & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- CTOR
- Stock Information
- Founded
- JRSH 2016
- CTOR 2021
- Country
- JRSH United States
- CTOR United States
- Employees
- JRSH N/A
- CTOR N/A
- Industry
- JRSH Apparel
- CTOR
- Sector
- JRSH Consumer Discretionary
- CTOR
- Exchange
- JRSH Nasdaq
- CTOR NYSE
- Market Cap
- JRSH 44.5M
- CTOR 48.1M
- IPO Year
- JRSH 2018
- CTOR N/A
- Fundamental
- Price
- JRSH $2.95
- CTOR $0.73
- Analyst Decision
- JRSH
- CTOR Strong Buy
- Analyst Count
- JRSH 0
- CTOR 2
- Target Price
- JRSH N/A
- CTOR $4.50
- AVG Volume (30 Days)
- JRSH 16.2K
- CTOR 3.8M
- Earning Date
- JRSH 02-11-2025
- CTOR 05-21-2025
- Dividend Yield
- JRSH 6.76%
- CTOR N/A
- EPS Growth
- JRSH N/A
- CTOR N/A
- EPS
- JRSH N/A
- CTOR N/A
- Revenue
- JRSH $138,135,034.00
- CTOR N/A
- Revenue This Year
- JRSH $29.89
- CTOR N/A
- Revenue Next Year
- JRSH $8.30
- CTOR N/A
- P/E Ratio
- JRSH N/A
- CTOR N/A
- Revenue Growth
- JRSH 15.70
- CTOR N/A
- 52 Week Low
- JRSH $2.68
- CTOR $0.55
- 52 Week High
- JRSH $4.17
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- JRSH 36.68
- CTOR N/A
- Support Level
- JRSH $2.85
- CTOR N/A
- Resistance Level
- JRSH $2.99
- CTOR N/A
- Average True Range (ATR)
- JRSH 0.13
- CTOR 0.00
- MACD
- JRSH 0.01
- CTOR 0.00
- Stochastic Oscillator
- JRSH 51.85
- CTOR 0.00
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.